首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1764874

亞太器官保存解決方案市場預測（2031年）- 區域分析 - 按產品、應用、類型和最終用戶

Asia Pacific Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User

出版日期: 2025年04月17日 | 出版商:

The Insight Partners | 英文 138 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023 年亞太器官保存溶液市值為 37,978.81 萬美元，預計到 2031 年將達到 81,199.78 萬美元；預計 2024 年至 2031 年的複合年成長率為 10.1%。

市場參與者的策略性措施推動亞太器官保存解決方案市場

各市場參與者專注於產品發布或策略合作，以開發有助於簡化慢性病治療的先進產品。近年來，市場出現了各種發展態勢，例如產品發表、併購。

2022年4月，TransMedics Group, Inc. 的OCS心臟系統獲得美國食品藥物管理局（FDA）上市前批准，可用於循環死亡捐贈者器官的移植。 OCS心臟系統核准的擴展臨床適應症包括：體外復甦、功能監測以及循環死亡捐贈者心臟的跳動保存。

2023年8月，領先的器官移植公司Paragonix Technologies的下一代捐贈者肺部保存系統BAROguard獲得FDA批准。 BAROguard系統將Paragonix先進的低溫保存技術與自動化、持續和主動的氣道壓力控制相結合。此控制確保供體肺在從捐贈者轉移到接受者的整個過程中保持最佳溫度範圍和臨床建議的充氣壓力範圍。這種新穎的先進技術組合進一步強化了公司持續致力於改進和重新定義移植醫學領域護理標準的承諾。

2024年4月，梅約診所與寺崎生物醫學創新研究所合作，旨在改善器官移植結果。梅奧診所的生物醫學研究人員和寺崎研究所的科學家計劃在兩個主要研究領域展開合作：即時監測捐贈器官從採購到移植手術的健康狀況，以及開發預測技術以識別具有較高排斥風險的移植接受者。這將涉及創建針對抗體介導的器官移植排斥反應的預後特徵和檢測方法。預計初期工程將在24至30個月內完成。

因此，產品核准、上市和策略合作的激增可能為未來器官保存解決方案市場創造相當大的成長機會。

亞太器官保存解決方案市場概覽

亞太地區的器官保存解決方案市場細分為中國、日本、印度、澳洲、韓國和亞太其他地區。該地區市場的成長歸因於亞太地區多個國家器官移植數量的成長、人口老化加劇、導致器官衰竭的慢性病盛行率上升以及器官保存解決方案的不斷發展和改進。中國預計將成為亞太地區最大的器官保存解決方案市場。中國市場的成長歸因於尋求器官移植的慢性病盛行率高。根據最近的一項名為《中國慢性病與老化》的研究，中國人口正在老化，慢性病在該國的盛行率日益上升。預計從2010年到2040年，中國60歲及以上人口的比例將從12.4%上升到28%。在中國，約80%的60歲人口死亡是由於慢性非傳染性疾病（NCD）造成的。慢性阻塞性肺病 (COPD)、中風、缺血性心臟病和第 2 型糖尿病是該國最常見的疾病。中國的肝癌發生率高於世界其他國家。根據世界衛生組織的數據，中國每年約有 40 萬人被診斷出罹患肝癌，約 36.8 萬人死於肝癌。儘管中國人口不到全球人口的 20%，但卻佔所有新發肝癌病例的近一半。肝細胞癌 (HCC) 約佔所有原發性肝癌的 90%。它主要發生在因慢性B型肝炎或C型肝炎而患有肝硬化或瘢痕的患者身上。糖尿病和肝癌等慢性疾病會導致器官損害。因此，中國的器官移植需求不斷增加，刺激了對器官保存解決方案的需求。

亞太器官保存解決方案市場收入及預測（2031 年）（千美元）

亞太器官保存解決方案市場區隔

亞太器官保存解決方案市場按產品、應用、類型、最終用戶和國家分類。

根據產品類型，亞太地區器官保存液市場可分為威斯康辛大學溶液、custodiol HTK、Perfadex、HypoThermosol 等。威斯康辛大學溶液在 2023 年佔據了最大的市場佔有率。

依應用分類，亞太地區器官保存液市場細分為靜態冷藏、低溫機械灌注、常溫機械灌注及其他。靜態冷藏領域在2023年佔據了最大的市場。

按類型分類，亞太器官保存解決方案市場分為腎臟、肝臟、肺臟、心臟和其他器官。腎臟器官在2023年佔據了最大的市場。

根據最終用戶，亞太地區器官保存解決方案市場細分為器官移植中心、醫院和專科診所。器官移植中心在2023年佔據了最大的市場。

依國家/地區分類，亞太器官保存液市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2023年，中國佔據亞太器官保存液市場佔有率的主導地位。

XVIVO Perfusion、TransMedics、Dr. Franz Koehler Chemie GmbH、Accord Healthcare 和上海 Genext Pharmaceutical Technology 是亞太地區器官保存解決方案市場的領導公司。

In April 2022, TransMedics Group, Inc. received premarket FDA approval for its OCS Heart System for using it with organs procured from donors after circulatory death. The OCS Heart System is approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donors-after-circulatory-death (DCD) hearts.

In August 2023, Paragonix Technologies, a leading organ transplant company, received FDA clearance for its next-generation donor lung preservation system-BAROguard. The BAROguard system combines Paragonix's advanced hypothermic preservation technology with automated continuous and active airway pressure control. This control ensures the maintenance of optimal temperature range and a clinically recommended inflation pressure range for donor's lungs throughout their transfer from donors to recipients. This novel combination of advanced technologies further reinforces the company's ongoing commitment to improving and redefining the standard of care within the field of transplant medicine.

In April 2024, the Mayo Clinic and the Terasaki Institute for Biomedical Innovation collaborated to improve organ transplant outcomes. Mayo Clinic biomedical researchers and Terasaki Institute scientists plan to collaborate on two main study areas: real-time monitoring of donated organ health from procurement to transplant surgery and the development of predictive technologies to identify transplant recipients with a higher risk of rejection. This will involve creating prognostic signatures and assays for antibody-mediated rejection of organ transplants. The initial projects are expected to be completed within 24-30 months.

Thus, a surge in product approvals, launches, and strategic collaborations is likely to create considerable growth opportunities for the organ preservation solution market in the future.

Asia Pacific Organ Preservation Solution Market Overview

The organ preservation solution market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in the region is attributed to the growing number of organ transplantations across several countries in Asia Pacific, increasing aging population, rising prevalence of chronic diseases that lead to organ failure, and increasing developments and improvements in organ preservation solutions. China is expected to be the largest market for organ preservation solutions in Asia Pacific. The market growth in the country is attributed to the high prevalence of chronic diseases seeking organ transplantation. According to a recent study, "Chronic Illness and Ageing in China," China's population is aging, and chronic illnesses are increasingly prevalent in the country. The proportion of people aged 60 years and above in China is expected to rise from 12.4% to 28% from 2010 to 2040. In China, ~80% of deaths of people aged 60 years are reported due to chronic noncommunicable diseases (NCDs). Chronic obstructive pulmonary disease (COPD), stroke, ischemic heart disease, and type 2 diabetes are among the most prevalent diseases in the country. China has a greater rate of liver cancer than other countries across the world. According to the World Health Organization, ~400,000 people are diagnosed with liver cancer, and around 368,000 people die due to the disease in China every year. Although accounting for less than 20% of the global population, China accounts for nearly half of all new liver cancer cases. Hepatocellular carcinoma (HCC) represents roughly 90 % of all occurrences of primary liver cancer. It develops mainly in those patients with cirrhosis, or scarring, due to chronic hepatitis B or C. Chronic diseases such as diabetes and liver cancer lead to organ damage. Therefore, the need for organ transplants has increased in China, bolstering the demand for organ preservation solutions.

Asia Pacific Organ Preservation Solution Market Revenue and Forecast to 2031 (US$ Thousand)

Asia Pacific Organ Preservation Solution Market Segmentation

The Asia Pacific organ preservation solution market is categorized into product, application, type, end user, and country.

Based on product, the Asia Pacific organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, HypoThermosol, and others. The University of Wisconsin segment held the largest market share in 2023.

In terms of application, the Asia Pacific organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest market share in 2023.

By type, the Asia Pacific organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest market share in 2023.

Based on end user, the Asia Pacific organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest market share in 2023.

By country, the Asia Pacific organ preservation solution market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific organ preservation solution market share in 2023.

XVIVO Perfusion, TransMedics, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, and Shanghai Genext Pharmaceutical Technology, are among the leading companies operating in the Asia Pacific organ preservation solution market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Asia Pacific Organ Preservation Solution Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Need for Organ Transplantation
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 Expensive Organ Transplant Surgeries
- 4.2.2 Limited Organ Availability
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Shift Toward Machine Perfusion Technique
4.5 Impact of Drivers and Restraints:

5. Organ Preservation Solution Market - Asia Pacific Analysis

5.1 Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
5.2 Organ Preservation Solution Market forecast Analysis

6. Asia Pacific Organ Preservation Solution Market Analysis - by Product

6.1 University of Wisconsin Solution
- 6.1.1 Overview
- 6.1.2 University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.2 Custodiol HTK
- 6.2.1 Overview
- 6.2.2 Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.3 Perfadex
- 6.3.1 Overview
- 6.3.2 Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.4 HypoThermosol
- 6.4.1 Overview
- 6.4.2 HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.5 Others
- 6.5.1 Overview
- 6.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

7. Asia Pacific Organ Preservation Solution Market Analysis - by Application

7.1 Static Cold Storage
- 7.1.1 Overview
- 7.1.2 Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.2 Hypothermic Machine Perfusion
- 7.2.1 Overview
- 7.2.2 Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.3 Normothermic Machine Perfusion
- 7.3.1 Overview
- 7.3.2 Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

8. Asia Pacific Organ Preservation Solution Market Analysis - by Type

8.1 Kidneys
- 8.1.1 Overview
- 8.1.2 Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.2 Liver
- 8.2.1 Overview
- 8.2.2 Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.3 Lungs
- 8.3.1 Overview
- 8.3.2 Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.4 Heart
- 8.4.1 Overview
- 8.4.2 Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

9. Asia Pacific Organ Preservation Solution Market Analysis - by End User

9.1 Organ Transplant Centers
- 9.1.1 Overview
- 9.1.2 Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
9.2 Hospitals
- 9.2.1 Overview
- 9.2.2 Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

10. Asia Pacific Organ Preservation Solution Market - Country Analysis

10.1 Asia Pacific
- 10.1.1 Asia Pacific: Organ Preservation Solution Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 10.1.1.1 Asia Pacific: Organ Preservation Solution Market - Revenue and forecast Analysis - by Country
  - 10.1.1.2 China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.2.1 China: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.2.2 China: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.2.3 China: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.2.4 China: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.3 Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.3.1 Japan: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.3.2 Japan: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.3.3 Japan: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.3.4 Japan: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.4 India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.4.1 India: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.4.2 India: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.4.3 India: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.4.4 India: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.5 Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.5.1 Australia: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.5.2 Australia: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.5.3 Australia: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.5.4 Australia: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.6 South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.6.1 South Korea: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.6.2 South Korea: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.6.3 South Korea: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.6.4 South Korea: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.7 Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.7.1 Rest of APAC: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.7.2 Rest of APAC: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.7.3 Rest of APAC: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.7.4 Rest of APAC: Organ Preservation Solution Market Breakdown, by End User

11. Organ Preservation Solutions Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in Organ Preservation Solutions Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 XVIVO Perfusion
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 TransMedics
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Dr. Franz Koehler Chemie GmbH
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Accord Healthcare
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Shanghai Genext Pharmaceutical Technology
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Organ Preservation Solution Market Segmentation
Table 2. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Table 3. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 4. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 5. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 6. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 7. Asia Pacific: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Country
Table 8. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 9. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 10. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 11. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 12. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 13. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 14. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 15. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 16. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 17. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 18. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 19. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 20. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 21. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 22. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 23. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 24. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 25. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 26. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 27. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 28. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
Table 29. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
Table 30. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
Table 31. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
Table 32. Recent Organic Growth Strategies in Organ Preservation Solutions Market
Table 33. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
Table 34. Glossary of Terms, Organ Preservation Solution Market

List Of Figures

Figure 1. Asia Pacific Organ Preservation Solution Market Segmentation, by Country
Figure 2. Organ Preservation Solution Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
Figure 5. Organ Preservation Solution Market Share (%) - by Product (2023 and 2031)
Figure 6. University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 7. Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 8. Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 9. HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 10. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 11. Organ Preservation Solution Market Share (%) - by Application (2023 and 2031)
Figure 12. Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 13. Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 14. Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 15. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 16. Organ Preservation Solution Market Share (%) - by Type (2023 and 2031)
Figure 17. Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 18. Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 19. Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 20. Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 21. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 22. Organ Preservation Solution Market Share (%) - by End User (2023 and 2031)
Figure 23. Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 24. Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 25. Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 26. Asia Pacific Organ Preservation Solution Market, by Key Country - Revenue (2023) (US$ Thousand)
Figure 27. Asia Pacific: Organ Preservation Solution Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 28. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 29. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 30. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 31. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 32. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 33. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
Figure 34. Growth Strategies in Organ Preservation Solutions Market